Syndax Pharmaceuticals Inc (SNDX)
Operating Cash Flow Growth
27.10%
TTM · Period ending:
SNDX Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported27.10%period ending
Latest reported27.10%period ending
SNDX TTM Cash from Operations YoY % (-201.19% → 27.10%)
Year-over-year change
High-resolution chart · PNG
SNDX operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 27.1014% | |
| 2.9157% | |
| -17.4887% | |
| -20.0939% | |
| -25.4864% | |
| -39.8183% | |
| -71.1714% | |
| -82.1114% | |
| -91.3684% | |
| -56.4617% | |
| -20.1429% | |
| -1,311.2986% | |
| -1,847.4197% | |
| -1,437.9508% | |
| -558.8754% | |
| 88.4507% | |
| 91.9664% | |
| 112.5622% | |
| 140.8799% | |
| -27.5806% | |
| -37.506% | |
| -56.7698% | |
| -40.7966% | |
| -29.149% | |
| 6.8079% | |
| 24.1037% | |
| 26.1473% | |
| 20.0604% | |
| -8.5391% | |
| -20.0081% | |
| -44.6687% | |
| -46.9211% | |
| -25.0151% | |
| -31.7488% | |
| -34.7413% | |
| -55.2039% | |
| -103.4783% | |
| -108.4021% | |
| -1,347.9819% | |
| -1,705.7214% | |
| -2,442.5926% | |
| -1,807.5601% | |
| 83.1307% | |
| 88.2405% | |
| 107.3642% | |
| 111.2769% | |
| -97.2995% | |
| -201.1851% |